Guardant Health
GH
#3260
Rank
S$4.82 B
Marketcap
$39.08
Share price
-3.64%
Change (1 day)
29.76%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of September 2024 : S$1.79 Billion

According to Guardant Health 's latest financial reports the company's total debt is S$1.79 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$1.78 B-2.6%
2022-12-31S$1.83 B-1.16%
2021-12-31S$1.85 B64.29%
2020-12-31S$1.13 B1975.68%
2019-12-31S$54.46 M
2018-12-31N/A-100%
2017-12-31S$0.88 M-96.43%
2016-12-31S$24.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$0.58 B-67.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.19 B-33.42%๐Ÿ‡บ๐Ÿ‡ธ USA